Abbott Laboratories (ABT)

$

9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
.
9
8
7
6
5
4
3
2
1
0
0
$0.18 (-0.16%)Past DayToday's Volume:
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
,
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
,
9
8
7
6
5
4
3
2
1
0
0

About

Business overview of Abbott Laboratories (ABT)
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.

Key Insights

Critical company metrics and information

  • Share Price

    $115.60

  • Market Cap

    $200.50 Billion

  • Total Outstanding Shares

    1.73 Billion Shares

  • Total Employees

    114,000

  • Dividend

    $0.55 Per Share Quarterly

  • IPO Date

    April 19, 1949

  • SIC Description

    Pharmaceutical Preparations

  • Homepage

    https://www.abbottinvestor.com

Historical Stock Splits

Execution DateSplit Amount
No Historical Stock Splits

Cash Flow Statement

October 1, 2023 to September 30, 2024
MetricValue
Net Cash Flow From Investing Activities, Continuing$-2.30 Billion
Net Cash Flow From Operating Activities$8.73 Billion
Net Cash Flow From Financing Activities, Continuing$-5.59 Billion
Net Cash Flow From Financing Activities$-5.59 Billion
Net Cash Flow From Investing Activities$-2.30 Billion
Net Cash Flow$837.00 Million
Net Cash Flow From Operating Activities, Continuing$8.73 Billion
Net Cash Flow, Continuing$837.00 Million

Income Statement

October 1, 2023 to September 30, 2024
MetricValue
Other Operating Expenses$1.89 Billion
Benefits Costs and Expenses$34.44 Billion
Net Income/Loss$5.77 Billion
Income/Loss From Continuing Operations After Tax$5.77 Billion
Basic Average Shares$1.74 Billion
Net Income/Loss Attributable To Noncontrolling Interest$0.00
Income Tax Expense/Benefit$1.01 Billion
Income/Loss From Continuing Operations Before Tax$6.78 Billion
Operating Expenses$16.20 Billion
Basic Earnings Per Share$3.31
Cost Of Revenue$18.32 Billion
Gross Profit$22.90 Billion
Operating Income/Loss$6.69 Billion
Diluted Earnings Per Share$3.29
Research and Development$2.79 Billion
Net Income/Loss Attributable To Parent$5.77 Billion
Costs And Expenses$34.52 Billion
Preferred Stock Dividends And Other Adjustments$23.00 Million
Selling, General, and Administrative Expenses$11.51 Billion
Revenues$41.22 Billion
Net Income/Loss Available To Common Stockholders, Basic$5.74 Billion
Diluted Average Shares$1.75 Billion
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic$23.00 Million

Balance Sheet

October 1, 2023 to September 30, 2024
MetricValue
Fixed Assets$10.62 Billion
Intangible Assets$7.35 Billion
Noncurrent Assets$50.55 Billion
Other Non-current Assets$32.58 Billion
Wages$1.62 Billion
Noncurrent Liabilities$19.43 Billion
Equity Attributable To Noncontrolling Interest$232.00 Million
Other Current Liabilities$13.28 Billion
Assets$74.36 Billion
Current Liabilities$14.90 Billion
Inventory$6.81 Billion
Equity Attributable To Parent$39.80 Billion
Liabilities$34.33 Billion
Other Current Assets$16.99 Billion
Equity$40.03 Billion
Current Assets$23.80 Billion
Liabilities And Equity$74.36 Billion

Historical Dividends

Current dividend: $0.55 Per Share Quarterly
Announcement DatePayment DateRecord DateAmountFrequency
Sep 19, 2024Nov 15, 2024Oct 15, 2024$0.55Quarterly
Jun 14, 2024Aug 15, 2024Jul 15, 2024$0.55Quarterly
Feb 16, 2024May 15, 2024Apr 15, 2024$0.55Quarterly
Dec 15, 2023Feb 15, 2024Jan 12, 2024$0.55Quarterly
Sep 21, 2023Nov 15, 2023Oct 13, 2023$0.51Quarterly
Jun 9, 2023Aug 15, 2023Jul 14, 2023$0.51Quarterly
Feb 17, 2023May 15, 2023Apr 14, 2023$0.51Quarterly
Dec 9, 2022Feb 15, 2023Jan 13, 2023$0.51Quarterly
Sep 15, 2022Nov 15, 2022Oct 14, 2022$0.47Quarterly
Jun 10, 2022Aug 15, 2022Jul 15, 2022$0.47Quarterly
Feb 18, 2022May 16, 2022Apr 15, 2022$0.47Quarterly
Dec 10, 2021Feb 15, 2022Jan 14, 2022$0.47Quarterly
Sep 15, 2021Nov 15, 2021Oct 15, 2021$0.45Quarterly
Jun 11, 2021Aug 16, 2021Jul 15, 2021$0.45Quarterly
Feb 19, 2021May 17, 2021Apr 15, 2021$0.45Quarterly
Dec 11, 2020Feb 16, 2021Jan 15, 2021$0.45Quarterly
Sep 17, 2020Nov 16, 2020Oct 15, 2020$0.36Quarterly
Jun 12, 2020Aug 17, 2020Jul 15, 2020$0.36Quarterly
Feb 21, 2020May 15, 2020Apr 15, 2020$0.36Quarterly
Dec 13, 2019Feb 14, 2020Jan 15, 2020$0.36Quarterly
Sep 12, 2019Nov 15, 2019Oct 15, 2019$0.32Quarterly
Jun 14, 2019Aug 15, 2019Jul 15, 2019$0.32Quarterly
Feb 22, 2019May 15, 2019Apr 15, 2019$0.32Quarterly
Dec 14, 2018Feb 15, 2019Jan 15, 2019$0.32Quarterly
Sep 13, 2018Nov 15, 2018Oct 15, 2018$0.28Quarterly
Jun 8, 2018Aug 15, 2018Jul 13, 2018$0.28Quarterly
Feb 16, 2018May 15, 2018Apr 13, 2018$0.28Quarterly
Dec 15, 2017Feb 15, 2018Jan 12, 2018$0.28Quarterly
Sep 14, 2017Nov 15, 2017Oct 13, 2017$0.265Quarterly
Jun 9, 2017Aug 15, 2017Jul 14, 2017$0.265Quarterly
Feb 17, 2017May 15, 2017Apr 14, 2017$0.265Quarterly
Dec 9, 2016Feb 15, 2017Jan 13, 2017$0.265Quarterly
Sep 15, 2016Nov 15, 2016Oct 14, 2016$0.26Quarterly
Jun 10, 2016Aug 15, 2016Jul 15, 2016$0.26Quarterly
Feb 19, 2016May 16, 2016Apr 15, 2016$0.26Quarterly
Dec 11, 2015Feb 16, 2016Jan 15, 2016$0.26Quarterly
Sep 17, 2015Nov 15, 2015Oct 15, 2015$0.24Quarterly
Jun 12, 2015Aug 15, 2015Jul 15, 2015$0.24Quarterly
Feb 20, 2015May 15, 2015Apr 15, 2015$0.24Quarterly
Dec 12, 2014Feb 13, 2015Jan 15, 2015$0.24Quarterly
Sep 11, 2014Nov 15, 2014Oct 15, 2014$0.22Quarterly
Jun 13, 2014Aug 15, 2014Jul 15, 2014$0.22Quarterly
Feb 21, 2014May 15, 2014Apr 15, 2014$0.22Quarterly
Oct 16, 2013Feb 15, 2014Jan 15, 2014$0.22Quarterly
Sep 12, 2013Nov 15, 2013Oct 15, 2013$0.14Quarterly
Jun 14, 2013Aug 15, 2013Jul 15, 2013$0.14Quarterly
Feb 15, 2013May 15, 2013Apr 15, 2013$0.14Quarterly
Dec 14, 2012Feb 15, 2013Jan 15, 2013$0.14Quarterly
Sep 13, 2012Nov 15, 2012Oct 15, 2012$0.51Quarterly

Related Companies

View additional S&P 500 companies similar to Abbott Laboratories (ABT)
Boost your savings and earn 4.35% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.
Earnings CalendarNews ArticlesAbout UsPrivacy & Cookies Info

ⓒ 2024 Financhle. All Rights Reserved.